Here are seven observations:
1. In 2012, the market was worth $29.2 billion.
2. The global market will grow at a compound annual growth rate of 4.9 percent through 2019.
3. The increasing number of osteoarthritis and osteoporosis cases as well as the growing number of sports and road injuries will drive the global orthopedic devices market.
4. Product recalls, economic uncertainty and political reforms may deter the market.
5. The knee segment led the market by anatomical location, but the hip segment will grow at a 5.9 CAGR through 2019.
6. North America will continue to lead the global orthopedic devices market, with Europe following in second. The Asia-Pacific region will grow at the greatest pace through 2019.
7. Dominant market players include DePuy Synthes, Smith & Nephew, Zimmer Biomet, Globus Medical, Medtronic, TriMed, Integra LifeSciences, aap Implantate, Vilex, Small Bone Innovations, Orthofix, Solana Surgical, Conmed, NuVasive, Aesculap, ArthroCare, Stryker, Arthrex and Wright Medical Technology.
More articles on devices:
Hospital for Special Surgery partners with pSivida to develop drug releasing implant: 5 things to know
DePuy Synthes to provide financing options for orthopedic surgery table: 4 key notes
NuVasive acquires SafePassage to expand neuromonitoring business: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
